The Czech Republic and Portugal are two of the European cannabis industries’ most crucial markets.
Both have a population of around 10m, both were European pioneers in cannabis decriminalisation, and before Portugal’s recent government dissolution, both looked to be targeting adult-use legalisation.
Despite comparable beginnings and a shared liberal outlook on cannabis, the country’s respective cannabis industries have developed into very different beasts.
Business of Cannabis spoke to Sean Carney, Founder of Herbology Ventures and former Director of Business Development at Tilray, to explore why they have taken such different paths, and where these could lead them in future.
Portugal is a market where medical cannabis treatment is legal, but patient numbers are extremely low due to the lack of a developed infrastructure for treatment.